Furthermore, GSK-3 protein expression is inversely correlated with MCL1 expression in primary breast cancer patient tissue, and increased levels of MCL-1 protein in this patient cohort are associated with worse prognosis [79]. The gene discussed is MCL1; the disease is breast carcinoma.